Unregistered Medicines Support
Section 21 Companies
- Regulatory guidance for Section 21 applications
- Licensing and compliance advisory aligned with SAHPRA and regional NRAs
- Quality assurance systems and regulatory documentation support
- Business development, funding readiness, and sustainability planning
- Market access strategy for transition from Section 21 authorization to full product registration